Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIO)

223.57
Delayed Data
As of Oct 23
 +1.63 / +0.73%
Today’s Change
154.89
Today|||52-Week Range
242.79
+22.65%
Year-to-Date
New Strong Sell Stocks for October 20th
Oct 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close221.94
Today’s open222.43
Day’s range221.69 - 225.19
Volume175,171
Average volume (3 months)159,750
Market cap$5.4B
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)-75.32%
Earnings growth (this year)+200.07%
Earnings growth (next 5 years)+19.99%
Revenue growth (last year)+2.41%
P/E ratio447.1
Price/Sales2.61
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp-0.06-0.20%
PKIPerkinElmer Inc-0.09-0.13%
QGENQiagen NV+0.01+0.03%
AXDXAccelerate Diagnosti...-0.35-1.76%
Data as of 10/23/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$2.1B
Annual profit (last year)$28.1M
Net profit margin1.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts